These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A preliminary report on the use of the depot sulphone preparation acedapsone ("Hansolar") in the control of leprosy. Boughton CR; Scott GC; Russell DA; Vincin DR Med J Aust; 1971 Jun; 1(24):1258-63. PubMed ID: 4935561 [No Abstract] [Full Text] [Related]
3. Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD). Ozawa T; Shepard CC; Karat AB Am J Trop Med Hyg; 1971 Mar; 20(2):274-81. PubMed ID: 4928595 [No Abstract] [Full Text] [Related]
4. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse. Levy L; Peters JH Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808 [No Abstract] [Full Text] [Related]
9. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
10. Progress in leprosy research. WHO Chron; 1966 Mar; 20(3):98-100. PubMed ID: 5325357 [No Abstract] [Full Text] [Related]
11. Advances in leprosy control in the last 100 years. Bechelli LM Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732 [No Abstract] [Full Text] [Related]
12. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy. Hastings RC; Trautman JR Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649 [No Abstract] [Full Text] [Related]
13. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
14. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980]. Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000 [No Abstract] [Full Text] [Related]
15. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796 [TBL] [Abstract][Full Text] [Related]
16. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
17. Treatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea. Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR Am J Trop Med Hyg; 1971 May; 20(3):495-501. PubMed ID: 4932529 [No Abstract] [Full Text] [Related]
18. Primary dapsone-resistant leprosy in San Francisco. Gelber RH Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067 [TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility testing of Mycobacterium leprae. Baohong J Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575 [No Abstract] [Full Text] [Related]
20. Growth of sulfone-resistant M. leprae in the foot pads of mice fed dapsone. Hastings RC Proc Soc Exp Biol Med; 1977 Dec; 156(3):544-5. PubMed ID: 339229 [No Abstract] [Full Text] [Related] [Next] [New Search]